---
title: "ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionTMCI"
description: "NEW YORK, April 26, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. TMCI between May 8, 2023 and Ma"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/237660878.md"
published_at: "2025-04-26T14:02:25.000Z"
---

# ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionTMCI

> NEW YORK, April 26, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. TMCI between May 8, 2023 and May 7, 2024, both dates inclusive ( the "Class Period" ) , of the important June 10, 2025 lead ...

NEW YORK, April 26, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. TMCI between May 8, 2023 and May 7, 2024, both dates inclusive ( the "Class Period" ) , of the important June 10, 2025 lead ...

### Related Stocks

- [TMCI.US - Treace Medical Concepts](https://longbridge.com/en/quote/TMCI.US.md)
- [NVEC.US - NVE](https://longbridge.com/en/quote/NVEC.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Treace Medical Concepts｜8-K：2025 财年 Q4 营收 62.3 百万美元超过预期 |  | [Link](https://longbridge.com/en/news/272423505.md) |
| Treace Medical Concepts 的首席执行官将在摩根大通医疗健康大会上进行演讲 | Treace Medical Concepts Inc. 将在第 44 届年度摩根大通医疗健康会议上进行演讲，首席执行官 John T. Treace 定于 2026 年 1 月 14 日上午 7:30（太平洋时间）发言。公司投资者关系网站 | [Link](https://longbridge.com/en/news/271140290.md) |
| Treace Medical Concepts (TMCI) 获得 Stifel Nicolaus 的持有评级 | Rick Wise 来自 Stifel Nicolaus 对 Treace Medical Concepts (TMCI) 维持了持有评级，目标价为 3.00 美元。分析师对 TMCI 的共识评级也是持有，目标价共识为 4.87 美元。Wi | [Link](https://longbridge.com/en/news/271789921.md) |
| Treace Medical Concepts, Inc. (NASDAQ:TMCI) 被多家券商给予平均评级为 “减持” | Treace Medical Concepts, Inc. (NASDAQ:TMCI) 收到了六家研究公司的平均评级为 “减持”。两位分析师建议卖出，而四位分析师建议持有该股票。平均一年的目标价为 4.21 美元。最近的报告显示，各公司下调 | [Link](https://longbridge.com/en/news/276104252.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.